Patents by Inventor Marius Monshouwer

Marius Monshouwer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF BIOMARKERS TO EVALUATE THE EFFICACY OF A COMPOSITION IN REDUCING THE EFFECTS OF CANCER THERAPEUTICS ON SKIN
    Publication number: 20220057383
    Abstract: A method to evaluate the potential of cancer therapeutics to produce skin related side effects is disclosed. The method, which involves use of biological markers, can also be used to evaluate the efficacy of a composition in reducing the effects of cancer therapeutics on skin.
    Type: Application
    Filed: October 29, 2020
    Publication date: February 24, 2022
    Inventors: Thomas Ondet, Marius Monshouwer, Georgios N. Stamatas, Pierre-Francois Roux
  • Method to potentiate the therapeutic efficacy of taxane and derivatives thereof
    Publication number: 20030153539
    Abstract: The use of estramustine phosphate and its metabolites estramusfine and estromustine allow to potentiate the therapeutic efficacy of taxanes by both improving their pharmacokinetic and pharmacodynamidc profile through the inhibition of (CYP)2C8 and (CYP)3A4 enzymes, both responsible for the metabolism of the taxanes; formulations of estramustine phosphate and metabolites, combinations of these latter with taxanes and therapeutic methods of treatment comprising them as a combined therapy are also disclosed.
    Type: Application
    Filed: December 12, 2002
    Publication date: August 14, 2003
    Inventors: Marius Monshouwer, Robert Ings, Maurizio Rocchetti